$SSY
SUNLINK HEALTH SYSTEMS INC

2015 Q4 Form 10-Q Financial Statement

#000119312516465271 Filed on February 16, 2016

View on sec.gov

Income Statement

Concept 2015 Q4 2014 Q4
Revenue $16.59M $25.11M
YoY Change -33.95% -3.84%
Cost Of Revenue $880.0K $1.162M
YoY Change -24.27% -13.93%
Gross Profit $15.71M $23.95M
YoY Change -34.41% -3.29%
Gross Profit Margin 94.69% 95.37%
Selling, General & Admin $10.06M $14.10M
YoY Change -28.65% -2.96%
% of Gross Profit 64.06% 58.88%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $450.0K $580.0K
YoY Change -22.41% -23.98%
% of Gross Profit 2.87% 2.42%
Operating Expenses $12.48M $16.64M
YoY Change -25.0% -2.69%
Operating Profit -$1.262M $2.022M
YoY Change -162.41% 594.85%
Interest Expense $209.0K $234.0K
YoY Change -10.68% -1.68%
% of Operating Profit 11.57%
Other Income/Expense, Net $1.970M $1.970M
YoY Change 0.0% 51.77%
Pretax Income -$1.465M $1.788M
YoY Change -181.94% 3273.58%
Income Tax $7.101M $799.0K
% Of Pretax Income 44.69%
Net Earnings -$9.346M $977.0K
YoY Change -1056.6% 330.4%
Net Earnings / Revenue -56.35% 3.89%
Basic Earnings Per Share -$0.99 $0.10
Diluted Earnings Per Share -$0.99 $0.10
COMMON SHARES
Basic Shares Outstanding 9.443M shares 9.443M shares
Diluted Shares Outstanding 9.443M shares 9.497M shares

Balance Sheet

Concept 2015 Q4 2014 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $3.700M $4.000M
YoY Change -7.5% -13.04%
Cash & Equivalents $3.742M $3.971M
Short-Term Investments
Other Short-Term Assets $2.500M $8.500M
YoY Change -70.59% -16.67%
Inventory $3.648M $4.047M
Prepaid Expenses
Receivables $9.100M $2.672M
Other Receivables $0.00 $0.00
Total Short-Term Assets $18.99M $27.66M
YoY Change -31.33% -7.5%
LONG-TERM ASSETS
Property, Plant & Equipment $22.09M $22.82M
YoY Change -3.22% -23.33%
Goodwill $461.0K $461.0K
YoY Change 0.0% 0.0%
Intangibles $2.766M $2.908M
YoY Change -4.88% -6.28%
Long-Term Investments
YoY Change
Other Assets $1.400M $1.550M
YoY Change -9.68% 3.68%
Total Long-Term Assets $26.72M $32.18M
YoY Change -16.98% -16.68%
TOTAL ASSETS
Total Short-Term Assets $18.99M $27.66M
Total Long-Term Assets $26.72M $32.18M
Total Assets $45.71M $59.84M
YoY Change -23.61% -12.68%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $4.697M $5.433M
YoY Change -13.55% -6.6%
Accrued Expenses $722.0K $6.200M
YoY Change -88.35% 6.9%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $8.246M $866.0K
YoY Change 852.19% 0.12%
Total Short-Term Liabilities $17.99M $12.61M
YoY Change 42.71% -21.81%
LONG-TERM LIABILITIES
Long-Term Debt $3.333M $11.58M
YoY Change -71.22% -31.63%
Other Long-Term Liabilities $652.0K $786.0K
YoY Change -17.05% -1.63%
Total Long-Term Liabilities $5.131M $13.33M
YoY Change -61.5% -31.85%
TOTAL LIABILITIES
Total Short-Term Liabilities $17.99M $12.61M
Total Long-Term Liabilities $5.131M $13.33M
Total Liabilities $23.12M $25.94M
YoY Change -10.85% -27.31%
SHAREHOLDERS EQUITY
Retained Earnings $4.717M $16.05M
YoY Change -70.61% 6.29%
Common Stock $18.24M $18.19M
YoY Change 0.31% 285.13%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $22.60M $33.90M
YoY Change
Total Liabilities & Shareholders Equity $45.71M $59.84M
YoY Change -23.61% -12.68%

Cashflow Statement

Concept 2015 Q4 2014 Q4
OPERATING ACTIVITIES
Net Income -$9.346M $977.0K
YoY Change -1056.6% 330.4%
Depreciation, Depletion And Amortization $450.0K $580.0K
YoY Change -22.41% -23.98%
Cash From Operating Activities -$100.0K $890.0K
YoY Change -111.24% -23.28%
INVESTING ACTIVITIES
Capital Expenditures $362.0K $319.0K
YoY Change 13.48% -21.43%
Acquisitions
YoY Change
Other Investing Activities $0.00 $6.090M
YoY Change -100.0% -7712.5%
Cash From Investing Activities -$370.0K $5.770M
YoY Change -106.41% -1302.08%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -290.0K -4.770M
YoY Change -93.92% 1438.71%
NET CHANGE
Cash From Operating Activities -100.0K 890.0K
Cash From Investing Activities -370.0K 5.770M
Cash From Financing Activities -290.0K -4.770M
Net Change In Cash -760.0K 1.890M
YoY Change -140.21% 410.81%
FREE CASH FLOW
Cash From Operating Activities -$100.0K $890.0K
Capital Expenditures $362.0K $319.0K
Free Cash Flow -$462.0K $571.0K
YoY Change -180.91% -24.27%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2016Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
9443408 shares
CY2014Q3 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
7330000
CY2014Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
7279000
CY2014Q4 us-gaap Assets
Assets
59838000
CY2014Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
3971000
CY2015Q3 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
5225000
CY2015Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
9444000 shares
CY2015Q4 us-gaap Common Stock No Par Value
CommonStockNoParValue
CY2015Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
2000000 shares
CY2015Q4 us-gaap Preferred Stock Share Subscriptions
PreferredStockShareSubscriptions
2000000 shares
CY2015Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
9444000 shares
CY2015Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
5131000
CY2015Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
13521000
CY2015Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
2798000
CY2015Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
3333000
CY2015Q4 us-gaap Capital Lease Obligations
CapitalLeaseObligations
41000
CY2015Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
652000
CY2015Q4 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
0
CY2015Q4 us-gaap Long Term Debt
LongTermDebt
11579000
CY2015Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
1528000
CY2015Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
8246000
CY2015Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
4697000
CY2015Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
4487000
CY2015Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
722000
CY2015Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
4717000
CY2015Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
45708000
CY2015Q4 us-gaap Common Stock Value
CommonStockValue
4722000
CY2015Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2015Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
22586000
CY2015Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
33310000
CY2015Q4 us-gaap Liabilities Current
LiabilitiesCurrent
17991000
CY2015Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
7384000
CY2015Q4 us-gaap Preferred Stock Value
PreferredStockValue
0
CY2015Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-374000
us-gaap Health Care Organization Significant Changes In Estimates
HealthCareOrganizationSignificantChangesInEstimates
-297000
CY2015Q4 us-gaap Receivables Net Current
ReceivablesNetCurrent
9067000
CY2015Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1400000
CY2014Q4 ssy Health Care Organization Medicare And Medicaid Electronic Health Records Incentives Gain Loss
HealthCareOrganizationMedicareAndMedicaidElectronicHealthRecordsIncentivesGainLoss
0
CY2015Q4 us-gaap Other Assets Miscellaneous Noncurrent
OtherAssetsMiscellaneousNoncurrent
4627000
CY2015Q4 us-gaap Assets
Assets
45708000
CY2015Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
2766000
CY2015Q4 us-gaap Inventory Net
InventoryNet
3648000
CY2015Q4 us-gaap Unbilled Receivables Current
UnbilledReceivablesCurrent
0
CY2015Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
22088000
CY2015Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
0
CY2015Q4 us-gaap Assets Current
AssetsCurrent
18993000
CY2015Q4 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
8700000
CY2015Q4 us-gaap Goodwill
Goodwill
461000
CY2015Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
2536000
CY2015Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
3742000
CY2015Q4 us-gaap Deferred Tax Assets Net Noncurrent
DeferredTaxAssetsNetNoncurrent
0
CY2015Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
55398000
CY2015Q4 us-gaap Deferred Tax Assets Net Current
DeferredTaxAssetsNetCurrent
0
CY2015Q4 us-gaap Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
13554000
CY2015Q4 ssy Professional Liability Risks Non Current
ProfessionalLiabilityRisksNonCurrent
1146000
CY2014Q2 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
6903000
CY2014Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
3587000
CY2015Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
9444000 shares
CY2015Q2 us-gaap Common Stock No Par Value
CommonStockNoParValue
CY2015Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
2000000 shares
CY2015Q2 us-gaap Preferred Stock Share Subscriptions
PreferredStockShareSubscriptions
2000000 shares
CY2015Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
9444000 shares
CY2015Q2 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
12804000
CY2015Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
13481000
CY2015Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
3946000
CY2015Q2 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
11229000
CY2015Q2 us-gaap Capital Lease Obligations
CapitalLeaseObligations
137000
CY2015Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
681000
CY2015Q2 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
64000
CY2015Q2 us-gaap Long Term Debt
LongTermDebt
12045000
CY2015Q2 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
1479000
CY2015Q2 us-gaap Long Term Debt Current
LongTermDebtCurrent
816000
CY2015Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
4459000
CY2015Q2 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
5347000
CY2015Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
0
CY2015Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
15731000
CY2015Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
57128000
CY2015Q2 us-gaap Common Stock Value
CommonStockValue
4722000
CY2015Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2015Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
33560000
CY2015Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
32259000
CY2015Q2 us-gaap Liabilities Current
LiabilitiesCurrent
10764000
CY2015Q2 us-gaap Preferred Stock Value
PreferredStockValue
0
CY2015Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-374000
CY2015Q2 us-gaap Receivables Net Current
ReceivablesNetCurrent
9625000
CY2015Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1520000
CY2015Q2 us-gaap Other Assets Miscellaneous Noncurrent
OtherAssetsMiscellaneousNoncurrent
9703000
CY2015Q2 us-gaap Assets
Assets
57128000
CY2015Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
2837000
CY2015Q2 us-gaap Inventory Net
InventoryNet
3758000
CY2015Q2 us-gaap Unbilled Receivables Current
UnbilledReceivablesCurrent
1126000
CY2015Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
22333000
CY2015Q2 us-gaap Assets Current
AssetsCurrent
25092000
CY2015Q2 us-gaap Goodwill
Goodwill
461000
CY2015Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
2642000
CY2015Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
5974000
CY2015Q2 us-gaap Deferred Tax Assets Net Noncurrent
DeferredTaxAssetsNetNoncurrent
4885000
CY2015Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
54592000
CY2015Q2 us-gaap Deferred Tax Assets Net Current
DeferredTaxAssetsNetCurrent
1967000
CY2015Q2 us-gaap Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
14972000
CY2015Q2 ssy Professional Liability Risks Non Current
ProfessionalLiabilityRisksNonCurrent
894000
CY2015Q1 us-gaap Malpractice Insurance Description
MalpracticeInsuranceDescription
Claim made under its insurance policy covering, among other things, employee theft relating to misappropriation of funds by two now former employees over an eight year period beginning in 2006.
CY2015Q1 us-gaap Insurance Recoveries
InsuranceRecoveries
1000000
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.06
us-gaap Income Loss From Discontinued Operations Net Of Tax Per Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
-0.03
us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
0.09
us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
-0.03
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-52000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
9478000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
9443000 shares
us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
0.09
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.06
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
737000
us-gaap Insurance Recoveries
InsuranceRecoveries
1000000
us-gaap Net Income Loss
NetIncomeLoss
564000
us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
878000
us-gaap Gains Losses On Sales Of Assets
GainsLossesOnSalesOfAssets
0
us-gaap Sales Revenue Net
SalesRevenueNet
45502000
us-gaap Interest Paid
InterestPaid
562000
us-gaap Discontinued Operation Income Loss From Discontinued Operation During Phase Out Period Net Of Tax
DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodNetOfTax
-314000
us-gaap Discontinued Operation Income Loss From Discontinued Operation During Phase Out Period Before Income Tax
DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodBeforeIncomeTax
-359000
us-gaap Operating Income Loss
OperatingIncomeLoss
2327000
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
0
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
239000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
564000
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
29000
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
1863000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
985000
us-gaap Proceeds From Divestiture Of Businesses
ProceedsFromDivestitureOfBusinesses
6090000
us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
677000
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
384000
us-gaap Interest Expense
InterestExpense
464000
us-gaap Cost Of Services
CostOfServices
2498000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-4906000
us-gaap Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
6001000
us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
122000
us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
175000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
21000
us-gaap Supplies Expense
SuppliesExpense
3844000
us-gaap Health Care Organization Patient Service Revenue Provisionfor Bad Debts
HealthCareOrganizationPatientServiceRevenueProvisionforBadDebts
4215000
us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
863000
us-gaap Labor And Related Expense
LaborAndRelatedExpense
21406000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
71000
us-gaap Cost Of Goods Sold
CostOfGoodsSold
10072000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
1215000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
5342000
us-gaap Discontinued Operation Tax Effect Of Income Loss From Discontinued Operation During Phase Out Period
DiscontinuedOperationTaxEffectOfIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriod
-236000
us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
4340000
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
123000
ssy Payments To Acquire Property Plant And Equipment Continuing Operations
PaymentsToAcquirePropertyPlantAndEquipmentContinuingOperations
737000
ssy Payments To Acquire Property Plant And Equipment Discontinued Operations
PaymentsToAcquirePropertyPlantAndEquipmentDiscontinuedOperations
11000
ssy Health Care Organization Medicare And Medicaid Electronic Health Records Incentives Gain Loss
HealthCareOrganizationMedicareAndMedicaidElectronicHealthRecordsIncentivesGainLoss
0
ssy Repayments Of Long Term Debt Discontinued Operations
RepaymentsOfLongTermDebtDiscontinuedOperations
4842000
ssy Financial And Healthcare Services Revenue
FinancialAndHealthcareServicesRevenue
49717000
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.17
us-gaap Nature Of Operations
NatureOfOperations
<div> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 18pt"> <b>Note 2. &#x2013; Business Operations</b></p> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt"> <u>Business Operations</u></p> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt; TEXT-INDENT: 4%"> SunLink Health Systems, Inc., through subsidiaries, owns businesses which are providers of healthcare services in certain markets in the United States. SunLink&#x2019;s business is composed of the ownership of two business segments:</p> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 6pt; MARGIN-TOP: 0pt"> &#xA0;</p> <table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" border="0"> <tr> <td width="5%">&#xA0;</td> <td valign="top" width="2%" align="left">&#x2022;</td> <td valign="top" width="1%">&#xA0;</td> <td valign="top" align="left">The Healthcare Facilities Segment which is composed of two operational areas:</td> </tr> </table> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 6pt; MARGIN-TOP: 0pt"> &#xA0;</p> <table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" border="0"> <tr> <td width="9%">&#xA0;</td> <td valign="top" width="3%" align="left">&#x2022;</td> <td valign="top" width="1%">&#xA0;</td> <td valign="top" align="left">Three community hospital subsidiaries in two states with a total of 183 licensed beds;</td> </tr> </table> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 6pt; MARGIN-TOP: 0pt"> &#xA0;</p> <table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" border="0"> <tr> <td width="9%">&#xA0;</td> <td valign="top" width="3%" align="left">&#x2022;</td> <td valign="top" width="1%">&#xA0;</td> <td valign="top" align="left">Two nursing homes with a total of 166 licensed beds, each of which is located adjacent to a corresponding SunLink community hospital; and</td> </tr> </table> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 6pt; MARGIN-TOP: 0pt"> &#xA0;</p> <table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" border="0"> <tr> <td width="5%">&#xA0;</td> <td valign="top" width="2%" align="left">&#x2022;</td> <td valign="top" width="1%">&#xA0;</td> <td valign="top" align="left">The Pharmacy Segment which is composed of four material service lines:</td> </tr> </table> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 6pt; MARGIN-TOP: 0pt"> &#xA0;</p> <table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" border="0"> <tr> <td width="9%">&#xA0;</td> <td valign="top" width="3%" align="left">&#x2022;</td> <td valign="top" width="1%">&#xA0;</td> <td valign="top" align="left">Retail pharmacy products and services, all of which are conducted in rural markets;</td> </tr> </table> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 6pt; MARGIN-TOP: 0pt"> &#xA0;</p> <table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" border="0"> <tr> <td width="9%">&#xA0;</td> <td valign="top" width="3%" align="left">&#x2022;</td> <td valign="top" width="1%">&#xA0;</td> <td valign="top" align="left">Institutional pharmacy services;</td> </tr> </table> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 6pt; MARGIN-TOP: 0pt"> &#xA0;</p> <table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" border="0"> <tr> <td width="9%">&#xA0;</td> <td valign="top" width="3%" align="left">&#x2022;</td> <td valign="top" width="1%">&#xA0;</td> <td valign="top" align="left">Pharmacy services; and</td> </tr> </table> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 6pt; MARGIN-TOP: 0pt"> &#xA0;</p> <table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" border="0"> <tr> <td width="9%">&#xA0;</td> <td valign="top" width="3%" align="left">&#x2022;</td> <td valign="top" width="1%">&#xA0;</td> <td valign="top" align="left">Durable medical equipment.</td> </tr> </table> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 12pt; TEXT-INDENT: 4%"> SunLink subsidiaries have conducted the healthcare facilities business since 2001 and the Pharmacy business since 2008. The Pharmacy Segment currently is operated through Carmichael&#x2019;s Cashway Pharmacy, Inc. (&#x201C;Carmichael&#x201D;), a subsidiary of SunLink ScriptsRx, LLC.</p> </div>
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2016
us-gaap Income Loss From Discontinued Operations Net Of Tax Per Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
-0.02
dei Amendment Flag
AmendmentFlag
false
dei Document Type
DocumentType
10-Q
dei Entity Central Index Key
EntityCentralIndexKey
0000096793
dei Entity Filer Category
EntityFilerCategory
Smaller Reporting Company
us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
-1.14
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--06-30
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-921000
dei Entity Registrant Name
EntityRegistrantName
SUNLINK HEALTH SYSTEMS INC
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
9443000 shares
us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
-0.02
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
9443000 shares
dei Document Period End Date
DocumentPeriodEndDate
2015-12-31
dei Trading Symbol
TradingSymbol
SSY
us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
-1.14
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.17
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
2 Segment
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
845000
us-gaap Insurance Recoveries
InsuranceRecoveries
0
us-gaap Net Income Loss
NetIncomeLoss
-11014000
us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
-10809000
us-gaap Gains Losses On Sales Of Assets
GainsLossesOnSalesOfAssets
7000
us-gaap Sales Revenue Net
SalesRevenueNet
40754000
us-gaap Interest Paid
InterestPaid
390000
us-gaap Discontinued Operation Income Loss From Discontinued Operation During Phase Out Period Net Of Tax
DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodNetOfTax
-205000
us-gaap Discontinued Operation Income Loss From Discontinued Operation During Phase Out Period Before Income Tax
DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodBeforeIncomeTax
-205000
us-gaap Operating Income Loss
OperatingIncomeLoss
-3538000
us-gaap Health Care Organization Significant Changes In Estimates
HealthCareOrganizationSignificantChangesInEstimates
-815000
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
0
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
466000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-11014000
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
76000
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-3957000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
6852000
us-gaap Proceeds From Divestiture Of Businesses
ProceedsFromDivestitureOfBusinesses
0
us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
643000
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-2232000
us-gaap Interest Expense
InterestExpense
426000
us-gaap Cost Of Services
CostOfServices
2584000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-466000
us-gaap Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
4054000
us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
642000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
39000
us-gaap Supplies Expense
SuppliesExpense
3307000
us-gaap Health Care Organization Patient Service Revenue Provisionfor Bad Debts
HealthCareOrganizationPatientServiceRevenueProvisionforBadDebts
2933000
us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
6210000
us-gaap Labor And Related Expense
LaborAndRelatedExpense
20900000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
71000
us-gaap Cost Of Goods Sold
CostOfGoodsSold
9968000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
1160000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-845000
us-gaap Discontinued Operation Tax Effect Of Income Loss From Discontinued Operation During Phase Out Period
DiscontinuedOperationTaxEffectOfIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriod
0
us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
5270000
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
360000
ssy Payments To Acquire Property Plant And Equipment Continuing Operations
PaymentsToAcquirePropertyPlantAndEquipmentContinuingOperations
845000
CY2014Q4 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
799000
CY2014Q4 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
329000
CY2014Q4 us-gaap Discontinued Operation Income Loss From Discontinued Operation During Phase Out Period Net Of Tax
DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodNetOfTax
-12000
CY2014Q4 us-gaap Discontinued Operation Income Loss From Discontinued Operation During Phase Out Period Before Income Tax
DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodBeforeIncomeTax
109000
CY2014Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
2022000
CY2014Q4 us-gaap Health Care Organization Significant Changes In Estimates
HealthCareOrganizationSignificantChangesInEstimates
-297000
CY2014Q4 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
0
CY2014Q4 us-gaap Interest Expense
InterestExpense
234000
CY2014Q4 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
977000
CY2014Q4 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
1788000
ssy Health Care Organization Medicare And Medicaid Electronic Health Records Incentives Gain Loss
HealthCareOrganizationMedicareAndMedicaidElectronicHealthRecordsIncentivesGainLoss
-100000
ssy Number Of Hospital Facilities
NumberOfHospitalFacilities
3 Hospital
ssy Financial And Healthcare Services Revenue
FinancialAndHealthcareServicesRevenue
43687000
CY2014Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.10
CY2014Q4 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
0.00
CY2014Q4 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
0.10
CY2014Q4 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
0.00
CY2014Q4 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
9497000 shares
CY2014Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
9443000 shares
CY2014Q4 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
0.10
CY2014Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.10
CY2014Q4 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
319000
CY2014Q4 us-gaap Insurance Recoveries
InsuranceRecoveries
1000000
CY2014Q4 us-gaap Net Income Loss
NetIncomeLoss
977000
CY2014Q4 us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
989000
CY2014Q4 us-gaap Gains Losses On Sales Of Assets
GainsLossesOnSalesOfAssets
0
CY2014Q4 us-gaap Sales Revenue Net
SalesRevenueNet
23126000
CY2014Q4 us-gaap Cost Of Services
CostOfServices
1162000
CY2014Q4 us-gaap Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
3239000
CY2014Q4 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
156000
CY2014Q4 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
15000
CY2014Q4 us-gaap Supplies Expense
SuppliesExpense
1897000
CY2014Q4 us-gaap Health Care Organization Patient Service Revenue Provisionfor Bad Debts
HealthCareOrganizationPatientServiceRevenueProvisionforBadDebts
1982000
CY2014Q4 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
643000
CY2014Q4 us-gaap Labor And Related Expense
LaborAndRelatedExpense
10589000
CY2014Q4 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
35000
CY2014Q4 us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
1968000
CY2014Q4 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
123000
CY2014Q4 us-gaap Cost Of Goods Sold
CostOfGoodsSold
5456000
CY2014Q4 us-gaap Depreciation And Amortization
DepreciationAndAmortization
580000
CY2014Q4 us-gaap Discontinued Operation Tax Effect Of Income Loss From Discontinued Operation During Phase Out Period
DiscontinuedOperationTaxEffectOfIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriod
-70000
CY2015Q4 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
9000
CY2015Q4 us-gaap Supplies Expense
SuppliesExpense
1649000
CY2015Q4 us-gaap Health Care Organization Patient Service Revenue Provisionfor Bad Debts
HealthCareOrganizationPatientServiceRevenueProvisionforBadDebts
1135000
CY2015Q4 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
6640000
CY2014Q4 ssy Financial And Healthcare Services Revenue
FinancialAndHealthcareServicesRevenue
25108000
CY2015Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.99
CY2015Q4 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
-0.01
CY2015Q4 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
-0.98
CY2015Q4 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
-0.01
CY2015Q4 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
9443000 shares
CY2015Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
9443000 shares
CY2015Q4 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
-0.98
CY2015Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.99
CY2015Q4 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
367000
CY2015Q4 us-gaap Insurance Recoveries
InsuranceRecoveries
0
CY2015Q4 us-gaap Net Income Loss
NetIncomeLoss
-9346000
CY2015Q4 us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
-9288000
CY2015Q4 us-gaap Gains Losses On Sales Of Assets
GainsLossesOnSalesOfAssets
6000
CY2015Q4 us-gaap Sales Revenue Net
SalesRevenueNet
20282000
CY2015Q4 us-gaap Discontinued Operation Income Loss From Discontinued Operation During Phase Out Period Net Of Tax
DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodNetOfTax
-58000
CY2015Q4 us-gaap Discontinued Operation Income Loss From Discontinued Operation During Phase Out Period Before Income Tax
DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodBeforeIncomeTax
19000
CY2015Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
-1779000
CY2015Q4 us-gaap Health Care Organization Significant Changes In Estimates
HealthCareOrganizationSignificantChangesInEstimates
-815000
CY2015Q4 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
0
CY2015Q4 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-9346000
CY2015Q4 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-1982000
CY2015Q4 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
7306000
CY2015Q4 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
310000
CY2015Q4 us-gaap Interest Expense
InterestExpense
209000
CY2015Q4 us-gaap Cost Of Services
CostOfServices
1291000
CY2015Q4 us-gaap Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
1978000
CY2015Q4 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
666000
CY2015Q4 us-gaap Labor And Related Expense
LaborAndRelatedExpense
10256000
CY2015Q4 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
35000
CY2015Q4 us-gaap Cost Of Goods Sold
CostOfGoodsSold
5371000
CY2015Q4 us-gaap Depreciation And Amortization
DepreciationAndAmortization
593000
CY2015Q4 us-gaap Discontinued Operation Tax Effect Of Income Loss From Discontinued Operation During Phase Out Period
DiscontinuedOperationTaxEffectOfIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriod
77000
CY2015Q4 us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
2446000
CY2015Q4 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
138000
CY2015Q4 ssy Health Care Organization Medicare And Medicaid Electronic Health Records Incentives Gain Loss
HealthCareOrganizationMedicareAndMedicaidElectronicHealthRecordsIncentivesGainLoss
-7000
CY2015Q4 ssy Financial And Healthcare Services Revenue
FinancialAndHealthcareServicesRevenue
21417000

Files In Submission

Name View Source Status
0001193125-16-465271-index-headers.html Edgar Link pending
0001193125-16-465271-index.html Edgar Link pending
0001193125-16-465271.txt Edgar Link pending
0001193125-16-465271-xbrl.zip Edgar Link pending
d19873d10q.htm Edgar Link pending
d19873dex311.htm Edgar Link pending
d19873dex312.htm Edgar Link pending
d19873dex321.htm Edgar Link pending
d19873dex322.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
ssy-20151231.xml Edgar Link completed
ssy-20151231.xsd Edgar Link pending
ssy-20151231_cal.xml Edgar Link unprocessable
ssy-20151231_def.xml Edgar Link unprocessable
ssy-20151231_lab.xml Edgar Link unprocessable
ssy-20151231_pre.xml Edgar Link unprocessable